法律人 LawPlayer logo

資料由法律人 LawPlayer整理提供·EU law / curated by LawPlayer from EUR-Lex

Decision

2014/236/EU: Commission Implementing Decision of 24 April 2014 concerning a Union financial contribution towards surveillance and other emergency measures implemented in Estonia, Latvia, Lithuania and Poland against African swine fever (notified under document C(2014) 2551)

CELEX
Date of document
Articles
6
Source
EUR-Lex
Article 1

1.   In the framework of the emergency measures for the protection against ASF taken by Estonia, Latvia, Lithuania and Poland in 2014, those Member States shall be entitled to a specific contribution from the Union to the expenditure incurred for the implementation of the activities described in paragraphs 2 and 3, and planned for the period from 1 January 2014 to 31 December 2014.

2.   The financial contribution by the Union shall be at the rate of 50 % of the costs incurred and paid for the implementation the following activities:

(a)

sampling of domestic pigs;

(b)

sampling of wild boar;

(c)

ELISA tests;

(d)

PCR and Sequencing tests;

(e)

purchase of equipment and disinfectant for cleansing and disinfection;

(f)

purchase of equipment especially used for disposal of animal carcasses;

(g)

purchase of equipment for carrying out virological laboratory tests;

(h)

awareness campaigns.

3.   The financial contribution by the Union shall be at the rate of 30 % of the costs incurred and paid by Lithuania and Poland for compensating pig owner for losses caused by early slaughter of pigs in the infected areas.

Article 2

1.   The maximum of the costs to be reimbursed to the Member States referred to in Article 1(1) for the activities referred to in Article 1(2) points (a), (b), (c) and (d) shall on average not exceed:

(a)

EUR 0,5 per domestic pig sampled;

(b)

EUR 5 per wild boar sampled;

(c)

EUR 2 per ELISA test;

(d)

EUR 10 per PCR and Sequencing test.

2.   The maximum of the costs to be reimbursed for the activity referred to in Article 1(2) point (e) shall on average not exceed:

(a)

EUR 6 000 for Estonia;

(b)

EUR 58 000 for Latvia;

(c)

EUR 950 000 for Lithuania;

(d)

EUR 102 100 for Poland.

3.   The maximum of the costs to be reimbursed for the activity referred to in Article 1(2) point (f) shall not exceed:

(a)

EUR 100 000 for Lithuania;

(b)

EUR 150 000 for Poland.

4.   The maximum of the costs to be reimbursed for the activity referred to in Article 1(2) point (g) shall not exceed:

EUR 75 000 for Lithuania.

5.   The maximum of the costs to be reimbursed for the activity referred to in Article 1(2) point (h) shall on average not exceed:

(a)

EUR 1 500 for Estonia;

(b)

EUR 15 000 for Latvia;

(c)

EUR 75 000 for Lithuania;

(d)

EUR 11 250 for Poland.

6.   The financial contribution by the Union to the Member States referred to in Article 1(3) shall not exceed:

(a)

EUR 225 000 for Lithuania;

(b)

EUR 337 500 for Poland.

7.   The financial contribution by the Union to the Member States referred to in Article 1(1) shall not exceed:

(a)

EUR 27 000 for Estonia;

(b)

EUR 190 000 for Latvia;

(c)

EUR 1 948 000 for Lithuania;

(d)

EUR 1 341 000 for Poland.

8.   The expenditure eligible for a financial contribution by the Union for the measures referred to in points c) and d) of paragraph 1 shall be limited to the costs incurred by the Member States for:

(a)

the purchase of test kits, reagents and all consumables identifiable and especially used for carrying out the laboratory tests;

(b)

personnel, whatever the status, specifically allocated entirely or in part for carrying out the tests in the premises of the laboratory, limited to actual salaries plus social security charges and other statutory costs included in the remuneration;

(c)

overheads equal to 7 % of the sum of the costs referred to in (a) and (b).

Article 3

1.   The financial contribution by the Union for the measures referred to in Article 1 shall be granted provided that the Member States concerned:

(a)

implement the activities and measures as described in their plans;

(b)

implement the measures in accordance with the relevant provisions of Union law, including rules on competition and on the award of public contracts;

(c)

forward to the Commission by 30 April 2015 at the latest a final technical report for the measures in accordance with Annex I and a final financial report in accordance with Annex II.

2.   Where a Member State does not comply with paragraph 1, the Commission may reduce the financial contribution by the Union in proportion to the nature and gravity of the infringement, and to the financial loss for the Union.

Article 4

This Decision is addressed to the Republic of Estonia, the Republic of Latvia, the Republic of Lithuania and the Republic of Poland.

Schedules & Appendices

ANNEX I

ANNEX I

Final technical report on surveillance measures in relation to African swine fever in wild boars and domestic pigs

Member State:

Date:

1.

Technical evaluation of the situation:

1.1.

Epidemiological maps:

1.2.

Information on surveillance:

Member State/Third country

Number of domestic pigs sampled

Number of wild boars sampled

Type of test  ( 1 )

Number of tests

Number of positive domestic pigs

Number of positive wild boars

Totals 2014

2.

Achievement of targets and technical difficulties:

3.

Additional epidemiological information: epidemiological inquiries, dead animals found, age distribution of positive reactors, lesions found, etc.:

( 1 )   Indicate: ELISA, PCR, Ag-ELISA, virus isolation, other (specify).

ANNEX II

ANNEX II

Final financial report on emergency measures in relation to African swine fever

Member State:

Date:

1.

Surveillance measures in relation to African swine fever in wild boars and domestic pigs:

Sampling

Category

Cost of sampling

Number of animals sampled

Unit cost per animal sampled

Total cost

Domestic pigs

Wild boar

Laboratory tests

Number of tests carried out

Cost of tests  ( *1 )

Laboratory test

(1)

Personnel

(2)

Overhead

(3)=(1)+(2)x0,07

Total Costs

(4)= (1)+(2)+(3)

Serological tests (ELISA)

PCR tests

Sequencing tests

2.

Cleansing and disinfection:

2(a)

EQUIPMENT

Description

Cost/value (excl. VAT)

Date of purchase

Total

2(b)

DISINFECTANT

Description

Cost/value (excl. VAT)

Date of purchase

Total

3.

EQUIPMENT AS MENTIONED IN ARTICLE 1, PARAGRAPH 2(f) AND (g)

Description

Cost/value (excl. VAT)

Date of purchase

Total

4.

COMPENSATION OF PIGS

Weight on date of destruction

Number of animals per category

Amount paid by category

Other costs paid directly to the farmer

(excluding VAT)

Total compensation

(excluding VAT)

Date of payment

sows

boars

piglets

pigs

sows

boars

piglets

pigs

5.

AWARENESS CAMPAIGNS:

Description of activities

Cost/value (excl. VAT)

Date of delivery

Total

6.

I certify that:

this expenditure was actually incurred, accurately accounted for and eligible under the provisions of this Decision,

all supporting documents relating to the expenditure are available for inspection,

no other Union contribution was requested for these measures and all revenue accruing from operations under them is declared to the Commission,

the measures were executed in accordance with the relevant Union legislation,

control procedures apply, in particular to verify the accuracy of the amounts declared, to prevent, detect and correct irregularities.

Date:

Name and signature of Operational Director:

( *1 )   All costs are VAT excluded

6 articles

Cite this act

2014/236/EU: Commission Implementing Decision of 24 April 2014 concerning a Union financial contribution towards surveillance and other emergency measures implemented in Estonia, Latvia, Lithuania and Poland against African swine fever (notified under document C(2014) 2551) (EUR-Lex). Retrieved via LawPlayer, https://lawplayer.com/eu/act/32014D0236

© European Union, https://eur-lex.europa.eu, 1998-2026. Reuse authorised under Commission Decision 2011/833/EU, provided the source is acknowledged.

EU-EurLex-Reuse-2011-833

本頁資料來源:EUR-Lex·整理提供:法律人 LawPlayer· lawplayer.com